Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Cellceutix Corporation - Product Pipeline Review - 2015

Published: Feb-2015 | Format: PDF | Global Markets Direct | Number of pages: 140 | Code: MRS - 7031


Global Markets Direct’s, ‘Cellceutix Corporation Product Pipeline Review 2015’, provides an overview of the Cellceutix Corporation’s pharmaceutical research and development focus.


This report provides comprehensive information on the current therapeutic developmental pipeline of Cellceutix Corporation’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.


Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.


The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.




The report provides brief overview of Cellceutix Corporation including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Cellceutix Corporation’s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the Cellceutix Corporation’s pipeline products


Reasons to buy


Evaluate Cellceutix Corporation’s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Cellceutix Corporation in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Cellceutix Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Cellceutix Corporation and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cellceutix Corporation
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Cellceutix Corporation and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues


Table of Contents

Table of Contents 2
List of Tables 5
List of Figures 5
Cellceutix Corporation Snapshot 6
Cellceutix Corporation Overview 6
Key Information 6
Key Facts 6
Cellceutix Corporation – Research and Development Overview 7
Key Therapeutic Areas 7
Cellceutix Corporation – Pipeline Review 13
Pipeline Products by Stage of Development 13
Pipeline Products – Monotherapy 14
Cellceutix Corporation – Pipeline Products Glance 15
Cellceutix Corporation – Clinical Stage Pipeline Products 15
Cellceutix Corporation – Early Stage Pipeline Products 17
Cellceutix Corporation – Drug Profiles 21
brilacidin 21
Kevetrin 23
KM-133 26
CTIX-1278 28
CTIX-1807 29
KM-277 30
KM-278 31
KM-3174 32
KM-362 33
KM-391 34
KM-732 36
PMX-0196 37
PMX-0231 38
PMX-0243 40
PMX-10072 41
PMX-10098 42
PMX-1207 43
PMX-1241 44
PMX-1278 45
PMX-1405 46
PMX-1408 47
PMX-1502 48
PMX-20005 49
PMX-207 50
PMX-225 51
PMX-496 52
PMX-504 53
PMX-519 54
PMX-611 55
PMX-647 56
PMX-835 57
PMX-100 58
PMX-10070 59
PMX-1014 60
PMX-1045 61
PMX-1056 62
PMX-1057 63
PMX-1090 64
PMX-1091 65
PMX-1094 66
PMX-1099 67
PMX-1102 68
PMX-1142 69
PMX-1363 70
PMX-1424 71
PMX-1442 72
PMX-1445 73
PMX-1467 74
PMX-1488 75
PMX-1533 76
PMX-1547 77
PMX-1555 78
PMX-1560 79
PMX-1570 80
PMX-1572 81
PMX-1573 82
PMX-1576 83
PMX-1591 84
PMX-1625 85
PMX-183 86
PMX-223 87
PMX-229 88
PMX-247 89
PMX-255 90
PMX-30016 91
PMX-30024 92
PMX-520 93
PMX-633 94
PMX-668 95
PMX-693 96
PMX-70004 97
PMX-728 98
PMX-741 99
PMX-843 100
PMX-868 101
Cellceutix Corporation – Pipeline Analysis 102
Cellceutix Corporation – Pipeline Products by Target 102
Cellceutix Corporation – Pipeline Products by Route of Administration 103
Cellceutix Corporation – Pipeline Products by Molecule Type 104
Cellceutix Corporation – Pipeline Products by Mechanism of Action 105
Cellceutix Corporation – Recent Pipeline Updates 106
Cellceutix Corporation – Dormant Projects 132
Cellceutix Corporation – Locations And Subsidiaries 133
Head Office 133


Appendix 134
Methodology 134
Coverage 134
Secondary Research 134
Primary Research 134
Expert Panel Validation 134
Contact Us 134
Disclaimer 135


List of Tables

Cellceutix Corporation, Key Information 11
Cellceutix Corporation, Key Facts 11
Cellceutix Corporation – Pipeline by Indication, 2015 13
Cellceutix Corporation – Pipeline by Stage of Development, 2015 18
Cellceutix Corporation – Monotherapy Products in Pipeline, 2015 19
Cellceutix Corporation – Phase II, 2015 20
Cellceutix Corporation – Phase I, 2015 21
Cellceutix Corporation – Preclinical, 2015 22
Cellceutix Corporation – Discovery, 2015 24
Cellceutix Corporation – Pipeline by Target, 2015 107
Cellceutix Corporation – Pipeline by Route of Administration, 2015 108
Cellceutix Corporation – Pipeline by Molecule Type, 2015 109
Cellceutix Corporation – Pipeline Products by Mechanism of Action, 2015 110
Cellceutix Corporation – Recent Pipeline Updates, 2015 111
Cellceutix Corporation – Dormant Developmental Projects,2015 137


List of Figures

Cellceutix Corporation – Pipeline by Top 10 Indication, 2015 13
Cellceutix Corporation – Pipeline by Stage of Development, 2015 18
Cellceutix Corporation – Monotherapy Products in Pipeline, 2015 19
Cellceutix Corporation – Pipeline by Top 10 Target, 2015 107
Cellceutix Corporation – Pipeline by Top 10 Route of Administration, 2015 108
Cellceutix Corporation – Pipeline by Top 10 Molecule Type, 2015 109
Cellceutix Corporation – Pipeline Products by Top 10 Mechanism of Action, 2015 110

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)1500 View Pricing